A large-scale RNAi screen in human cells identifies new components of the p53 pathway

Nature

Volumn 428, Issue 6981, 2004, Pages 431-437

  Berns, Katrien ^a   Hijmans, E Marielle ^a   Mullenders, Jasper ^a   Brummelkamp, Thljn R ^a   Velds, Arno ^a   Heimerikx, Mike ^a   Kerkhoven, Ron M ^a   Madlredjo, Mandy ^a   Nijkamp, Wouter ^a   Weigelt, Britta ^a   Agami, Reuven ^a   Ge, Wei ^b   Cavet, Guy ^b   Linsley, Peter S ^b   Beijersbergen, Roderick L ^a   Bernards, Rene ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b ROSETTA INPHARMATICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOSYNTHESIS; CELLS; GENETIC ENGINEERING; VECTORS;

GENE EXPRESSION; MAMMALIAN CELLS;

RNA;

PROTEIN P53; RETROVIRUS VECTOR;

RNA;

ARTICLE; CELL PROLIFERATION; GENE EXPRESSION; GENE INTERACTION; GENE REPRESSION; GENETIC CODE; GENETIC SCREENING; GENETIC STABILITY; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; RNA INTERFERENCE; RNA SYNTHESIS; SIGNAL TRANSDUCTION;

CELL DIVISION; CELL LINE, TUMOR; CLONING, MOLECULAR; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DOWN-REGULATION; FIBROBLASTS; GENE LIBRARY; GENETIC VECTORS; HUMANS; REPRODUCIBILITY OF RESULTS; RETROVIRIDAE; RNA INTERFERENCE; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53;

MAMMALIA; UNIDENTIFIED RETROVIRUS; VECTORS;

EID: 12144289681     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature02371     Document Type: Article

References (30)

1. Lum, L. et al. Identification of Hedgehog pathway components by RNAi in Drosophila cultured cells. Science 299, 2039-2045 (2003).
2. Kamath, R. S. et al. Systematic functional analysis of the Caenorhabilitis elegans genome using RNAi. Nature 421, 231-237 (2003).
3. Ashrafi, K. et al. Genome-wide RNAi analysis of Caenorhabilitis elegans fat regulatory genes. Nature 421, 268-272 (2003).
4. Brummelkamp, T. R., Bernards, R. & Agami, R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550-553 (2002).
5. Paddison, P. J., Caudy, A. A., Bernstein, E., Hannon, G. J. & Conklin, D. S. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev. 16, 948-958 (2002).
6. Hannon, G. J. RNA interference. Nature 418, 244-251 (2002).
7. Elbashir, S. M. et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498 (2001).
8. Sherr, C. J. The ink4a/ARF network in tumour suppression. Nature Rev. Mol. Cell Biol. 2, 731-737 (2001).
9. Brummelkamp, T., Bernards, R. & Agami, R. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2, 243-247 (2002).
10. Brummelkamp, T. R., Nijman, S. M., Dirac, A. M. & Bernards, R. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB. Nature 424, 797-801 (2003).
11. Semizarov, D. et al. Specificity of short interfering RNA determined through gene expression signatures. Proc. Natl Acad. Sci. USA 100, 6347-6352 (2003).
12. Jackson, A. L. et al. Expression profiling reveals off-target gene regulation by RNAi. Nature Biotechnol. 21, 635-637 (2003).
13. Kamijo, T. et al. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91, 649-659 (1997).
14. Lakin, N. D. & Jackson, S. P. Regulation of p53 in response to DNA damage. Oncogene 18, 7644-7655 (1999).
15. El-Deiry, W. S. et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825 (1993).
16. Brugarolas, J. et al. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377, 552-557 (1995).
17. Waldman, T., Kinzler, K. W. & Vogelstein B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res. 55, 5187-5190 (1995).
18. Brown, J. P., Wei, W. & Sedivy, J. M. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science 277, 831-834 (1997).
19. Miyashita, T. & Reed, J. C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, 293-299 (1995).
20. Barak, Y., Juven, T., Haffner, R. & Oren, M. mdm2 expression is induced by wild type p53 activity. EMBO J. 12, 461-468 (1993).
21. Kubbutat, M. H., Jones, S. N. & Vousden, K. H. Regulation of p53 stability by Mdm2. Nature 387, 299-303 (1997).
22. Brummelkamp, T. R. & Bernards, R. New tools for functional mammalian cancer genetics. Nature Rev. Cancer 3, 781-789 (2003).
23. Shoemaker, D. D., Lashkari, D. A., Morris, D., Mittmann, M. & Davis, R. W. Quantitative phenotypic analysis of yeast deletion mutants using a highly parallel molecular bar-coding strategy. Nature Genet. 14, 450-456 (1996).
24. Brummelkamp, T. R. et al. TBX-3, the gene mutated in Ulnar-Mammary Syndrome, is a negative regulator of p19ARF and inhibits senescence. J. Biol. Chem. 277, 6567-6572 (2002).
25. Kanda, T., Sullivan, K. F. & Wahl, G. M. Histone-GFP fusion protein enables sensitive analysis of chromosome dynamics in living mammalian cells. Curr. Biol. 8, 377-385 (1998).
26. Wang, A. H. et al. HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor. Mol. Cell. Biol. 19, 7816-7827 (1999).
27. Schwarz, D. S. et al. Asymmetry in the assembly of the RNAi enzyme complex. Cell 115, 199-208 (2003).
28. Heetebrij, R. J. et al. Platinum(II)-based coordination compounds as nucleic acid labeling reagents: synthesis, reactivity, and applications in hybridization assays. Chembiochem 4, 573-583 (2003).
29. Trettel, F. et al. Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells. Hum. Mol. Genet. 9, 2799-2809 (2000).
30. Dirac, A. M. & Bernards, R. Reversal of senescence in mouse fibroblasts through lentiviral suppression of p53. J. Biol. Chem. 278, 11731-11734 (2003).